4//SEC Filing
DEMAREE JOHN 4
Accession 0001562180-20-001009
CIK 0001560241other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:15 PM ET
Size
9.1 KB
Accession
0001562180-20-001009
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to Buy)
2020-02-06+30,000→ 30,000 totalExercise: $21.08Exp: 2030-02-06→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on February 06, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001744959
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:15 PM ET
- Size
- 9.1 KB